Phase-II Study of Recombinant α2-Interferon in Advanced Malignant Melanoma

Journal of Interferon Research ◽

10.1089/jir.1986.6.1 ◽

1986 ◽

Vol 6 (1) ◽

pp. 1-4 ◽

Author(s):

ALAN COATES ◽

MICHAEL RALLINGS ◽

PETER HERSEY ◽

CHERYL SWANSON

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Malignant Melanoma

Download Full-text

Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma

Melanoma Research ◽

10.1097/cmr.0b013e32832bbde6 ◽

2009 ◽

Vol 19 (3) ◽

pp. 185-192 ◽

Author(s):

Tim Eisen ◽

José Thomas ◽

Wilson H. Miller ◽

Martin Gore ◽

Pascal Wolter ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Advanced Malignant Melanoma

Download Full-text

Calm Study: Secondary Endpoints of a Phase Ii Study of a Novel Oncolytic Immunotherapeutic Agent, Coxsackievirus A21, Delivered Intratumorally in Patients with Advanced Malignant Melanoma

Annals of Oncology ◽

10.1093/annonc/mdu344.19 ◽

2014 ◽

Vol 25 ◽

pp. iv382

Author(s):

R.H. Andtbacka ◽

B. Curti ◽

H. Kaufman ◽

G.A. Daniels ◽

J.J. Nemunaitis ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Immunotherapeutic Agent ◽

Advanced Malignant Melanoma ◽

Secondary Endpoints ◽

Coxsackievirus A21

Download Full-text

Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-014-2479-8 ◽

2014 ◽

Vol 74 (1) ◽

pp. 77-84 ◽

Author(s):

Devalingam Mahalingam ◽

Laeeq Malik ◽

Muralidhar Beeram ◽

Jordi Rodon ◽

Kamalesh Sankhala ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Correlative Study ◽

Advanced Malignant Melanoma

Download Full-text

Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma. A phase II study of the eortc malignant melanoma cooperative group

Cancer ◽

10.1002/1097-0142(19880915)62:6<1061::aid-cncr2820620607>3.0.co;2-x ◽

1988 ◽

Vol 62 (6) ◽

pp. 1061-1065 ◽

Author(s):

C. F. Verschraegen ◽

U. R. Kleeberg ◽

J. Mulder ◽

P. Rumke ◽

F. Truchetet ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Cooperative Group ◽

Advanced Malignant Melanoma

Download Full-text

Positive phase II study in the treatment of advanced malignant melanoma with fotemustine

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00686343 ◽

1991 ◽

Vol 29 (1) ◽

pp. 85-87 ◽

Author(s):

Karin U. Schallreuter ◽

Eberhard Wenzel ◽

Frank W. Brassow ◽

J�rgen Berger ◽

Eckard W. Breitbart ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Positive Phase ◽

Advanced Malignant Melanoma

Download Full-text

Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: a phase II study

British Journal of Cancer ◽

10.1038/bjc.1990.137 ◽

1990 ◽

Vol 61 (4) ◽

pp. 618-621 ◽

Author(s):

N Thatcher ◽

H Dazzi ◽

M Mellor ◽

A Ghosh ◽

B Carrington ◽

...

Keyword(s):

Acetic Acid ◽

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Interleukin 2 ◽

Flavone Acetic Acid ◽

Advanced Malignant Melanoma ◽

Recombinant Interleukin 2

Download Full-text

A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-?2a in patients with advanced malignant melanoma

Cancer Immunology Immunotherapy ◽

10.1007/s002620050081 ◽

1994 ◽

Vol 38 (6) ◽

pp. 379-384 ◽

Author(s):

Ilan G. Ron ◽

Yair Mordish ◽

Avi Eisenthal ◽

Yehuda Skornick ◽

Moshe J. Inbar ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Interleukin 2 ◽

Home Therapy ◽

Advanced Malignant Melanoma ◽

Combined Administration ◽

Recombinant Interleukin 2

Download Full-text

Phase II study of continuous subcutaneous interferon-alfa combined with cisplatin in advanced malignant melanoma

European Journal of Cancer ◽

10.1016/0959-8049(92)90451-7 ◽

1992 ◽

Vol 28 (6-7) ◽

pp. 1044-1047 ◽

Author(s):

J Richner ◽

R.A Joss ◽

A Goldhirsch ◽

K.W Brunner

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Interferon Alfa ◽

Advanced Malignant Melanoma

Download Full-text

Sustained indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced malignant melanoma: A phase II study

Clinical Oncology ◽

10.1016/s0936-6555(05)80858-1 ◽

1993 ◽

Vol 5 (2) ◽

pp. 107-113 ◽

Author(s):

W.C. Mertens ◽

V.H.C. Bramwell ◽

D. Banerjee ◽

F. Gwadry-Sridhar ◽

P.K. Lala

Keyword(s):

Malignant Melanoma ◽

Continuous Infusion ◽

Phase Ii ◽

Phase Ii Study ◽

Interleukin 2 ◽

Advanced Malignant Melanoma

Download Full-text

413 Phase II study evaluating the efficacy, safety and pharmacodynamic correlative study of dual anti-angiogenic inhibition using Bevacizumab (B) in combination with Sorafenib (S) in patients (pts) with advanced malignant melanoma

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)72120-0 ◽

2010 ◽

Vol 8 (7) ◽

pp. 131

Author(s):

D. Mahalingam ◽

M. Beeram ◽

J. Rodon ◽

K. Sankhala ◽

A. Mita ◽

...

Keyword(s):

Malignant Melanoma ◽

Phase Ii ◽

Phase Ii Study ◽

Correlative Study ◽

Advanced Malignant Melanoma

Download Full-text